Investor Area

ICU Medical Technologies S.L. has developed KronoSafe System®, the first device that allows temporary cardiac pacing with active-fixation leads.

Number of current investors: 2

icu medical

ICU MEDICAL TECHNOLOGIES

ICU Medical Technologies S.L. is the Medical Device Company that has developed KronoSafe®. This System allows temporary cardiac pacing with active-fixation leads, adapting for external use the majority of definitive pacemaker generators and electrodes. According to current projections, it will be on sale by the end of 2021.

The increased safety and effectiveness provided by KronoSafe® allows the patient to be discharged from the Intensive Care Unit, freeing up necessary beds, especially during the COVID19 pandemic.

The initial investment round  will allow us to start sales at the European market, where more than 85,000 procedures per year are done. 

Now is the best moment to participate in the KronoSafe® Project.

MARKET

Temporary Cardiac Stimulation is a procedure performed 85,000 times a year in Europe, and more than 500,000 times a year worldwide.

USERS AND CUSTOMERS

Our users will be Intensive Care Physicians and Cardiologists in which we will reduce the complications of their patients using KronoSafe®.
Our customers will be the health systems, hospitals; to which we also provide financial savings: we will reduce the costs related to the treatment of complications and the hospital stay, liberating ICU beds for other patients.

INTELLECTUAL PROPERTY PROTECTION

Currently, the KronoSafe System® has all the Patents Reports favourable to reach National and Worldwide protection (PCT registry)

EXPERT ADVICE

The ICU Medical Technologies project has an Economic Viability Study carried out by an independent consultancy, supporting our projections.

Team

Ray Vicente

Ray Vicente

Founder and Chief Executive Officer (CEO)

David Vicente

David Vicente

CSO (Chief Strategy Officer)

Clara Gómez

Clara Gómez

COO (Chief Operations Officer) & Regulatory Affairs Manager

TOTAL INVESTMENT ROUND:

TARGET

European Market

  • Staff 55% 55%
  • Production and Commercialization 27% 27%
  • World Intellectual Property Protection 14% 14%
  • Other expenses 4% 4%

REQUEST OUR INVESTMENT DOSSIER

Get Started

CONTACT

5 + 15 =

OFfice

Edificio Innova – Universidad Miguel Hernández de Elche 

Avenida de la Universidad s/n 

03202 Elche, Alicante

ICU Medical Technologies S.L. - Copyright 2020 - Legal Notice - Privacy Policy - Cookies Policy

Si continúas usando este sitio, aceptas el uso de cookies. + Info

Los ajustes de cookies en esta web están configurados para «permitir las cookies» y ofrecerte la mejor experiencia de navegación posible. Si sigues usando esta web sin cambiar tus ajustes de cookies o haces clic en «Aceptar», estarás dando tu consentimiento a esto.

Cerrar